Finally, as the Partners cohort is actively followed, naïve CD4+ T cell counts and receptor repertoire can be trended over clinical course to determine whether loss co-occurs with or rather predates, and thus predicts, lymphoproliferative disease development in CVID. Here, CD4 is linked to common variable immunodeficiency.